293 related articles for article (PubMed ID: 28900031)
1. The metal chaperone Atox1 regulates the activity of the human copper transporter ATP7B by modulating domain dynamics.
Yu CH; Yang N; Bothe J; Tonelli M; Nokhrin S; Dolgova NV; Braiterman L; Lutsenko S; Dmitriev OY
J Biol Chem; 2017 Nov; 292(44):18169-18177. PubMed ID: 28900031
[TBL] [Abstract][Full Text] [Related]
2. In-silico analysis of novel p.(Gly14Ser) variant of ATOX1 gene: plausible role in modulating ATOX1-ATP7B interaction.
Kumari N; Kumar A; Pal A; Thapa BR; Modi M; Prasad R
Mol Biol Rep; 2019 Jun; 46(3):3307-3313. PubMed ID: 30980273
[TBL] [Abstract][Full Text] [Related]
3. The Structure of Metal Binding Domain 1 of the Copper Transporter ATP7B Reveals Mechanism of a Singular Wilson Disease Mutation.
Yu CH; Lee W; Nokhrin S; Dmitriev OY
Sci Rep; 2018 Jan; 8(1):581. PubMed ID: 29330485
[TBL] [Abstract][Full Text] [Related]
4. An EPR Study on the Interaction between the Cu(I) Metal Binding Domains of ATP7B and the Atox1 Metallochaperone.
Zaccak M; Qasem Z; Gevorkyan-Airapetov L; Ruthstein S
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32748830
[TBL] [Abstract][Full Text] [Related]
5. The structural flexibility of the human copper chaperone Atox1: Insights from combined pulsed EPR studies and computations.
Levy AR; Turgeman M; Gevorkyan-Aiapetov L; Ruthstein S
Protein Sci; 2017 Aug; 26(8):1609-1618. PubMed ID: 28543811
[TBL] [Abstract][Full Text] [Related]
6. Metallochaperone Atox1 transfers copper to the NH2-terminal domain of the Wilson's disease protein and regulates its catalytic activity.
Walker JM; Tsivkovskii R; Lutsenko S
J Biol Chem; 2002 Aug; 277(31):27953-9. PubMed ID: 12029094
[TBL] [Abstract][Full Text] [Related]
7. The six metal binding domains in human copper transporter, ATP7B: molecular biophysics and disease-causing mutations.
Ariöz C; Li Y; Wittung-Stafshede P
Biometals; 2017 Dec; 30(6):823-840. PubMed ID: 29063292
[TBL] [Abstract][Full Text] [Related]
8. Copper relay path through the N-terminus of Wilson disease protein, ATP7B.
Shanmugavel KP; Wittung-Stafshede P
Metallomics; 2019 Sep; 11(9):1472-1480. PubMed ID: 31321400
[TBL] [Abstract][Full Text] [Related]
9. Copper transfer to the N-terminal domain of the Wilson disease protein (ATP7B): X-ray absorption spectroscopy of reconstituted and chaperone-loaded metal binding domains and their interaction with exogenous ligands.
Ralle M; Lutsenko S; Blackburn NJ
J Inorg Biochem; 2004 May; 98(5):765-74. PubMed ID: 15134922
[TBL] [Abstract][Full Text] [Related]
10. Conformational dynamics of metal-binding domains in Wilson disease protein: molecular insights into selective copper transfer.
Rodriguez-Granillo A; Crespo A; Wittung-Stafshede P
Biochemistry; 2009 Jun; 48(25):5849-63. PubMed ID: 19449859
[TBL] [Abstract][Full Text] [Related]
11. Dynamics and stability of the metal binding domains of the Menkes ATPase and their interaction with metallochaperone HAH1.
Arumugam K; Crouzy S
Biochemistry; 2012 Nov; 51(44):8885-906. PubMed ID: 23075277
[TBL] [Abstract][Full Text] [Related]
12. NMR characterization of copper-binding domains 4-6 of ATP7B .
Fatemi N; Korzhnev DM; Velyvis A; Sarkar B; Forman-Kay JD
Biochemistry; 2010 Oct; 49(39):8468-77. PubMed ID: 20799727
[TBL] [Abstract][Full Text] [Related]
13. Metal binding domains 3 and 4 of the Wilson disease protein: solution structure and interaction with the copper(I) chaperone HAH1.
Banci L; Bertini I; Cantini F; Rosenzweig AC; Yatsunyk LA
Biochemistry; 2008 Jul; 47(28):7423-9. PubMed ID: 18558714
[TBL] [Abstract][Full Text] [Related]
14. Determinants for simultaneous binding of copper and platinum to human chaperone Atox1: hitchhiking not hijacking.
Palm-Espling ME; Andersson CD; Björn E; Linusson A; Wittung-Stafshede P
PLoS One; 2013; 8(7):e70473. PubMed ID: 23936210
[TBL] [Abstract][Full Text] [Related]
15. Probing functional roles of Wilson disease protein (ATP7B) copper-binding domains in yeast.
Ponnandai Shanmugavel K; Petranovic D; Wittung-Stafshede P
Metallomics; 2017 Jul; 9(7):981-988. PubMed ID: 28653724
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic and Structural Basis for Inhibition of Copper Trafficking by Platinum Anticancer Drugs.
Lasorsa A; Nardella MI; Rosato A; Mirabelli V; Caliandro R; Caliandro R; Natile G; Arnesano F
J Am Chem Soc; 2019 Jul; 141(30):12109-12120. PubMed ID: 31283225
[TBL] [Abstract][Full Text] [Related]
17. The N-terminal metal-binding site 2 of the Wilson's Disease Protein plays a key role in the transfer of copper from Atox1.
Walker JM; Huster D; Ralle M; Morgan CT; Blackburn NJ; Lutsenko S
J Biol Chem; 2004 Apr; 279(15):15376-84. PubMed ID: 14754885
[TBL] [Abstract][Full Text] [Related]
18. Unraveling Copper Exchange in the Atox1-Cu(I)-Mnk1 Heterodimer: A Simulation Approach.
Fortino M; Arnesano F; Pietropaolo A
J Phys Chem B; 2024 Jun; 128(22):5336-5343. PubMed ID: 38780400
[TBL] [Abstract][Full Text] [Related]
19. Cu(I) binding and transfer by the N terminus of the Wilson disease protein.
Yatsunyk LA; Rosenzweig AC
J Biol Chem; 2007 Mar; 282(12):8622-31. PubMed ID: 17229731
[TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of the interaction of the copper chaperone Atox1 with the metal binding sites of the Menkes protein.
Strausak D; Howie MK; Firth SD; Schlicksupp A; Pipkorn R; Multhaup G; Mercer JF
J Biol Chem; 2003 Jun; 278(23):20821-7. PubMed ID: 12679332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
